Mediclinic International Past Earnings Performance
Past criteria checks 4/6
Mediclinic International has been growing earnings at an average annual rate of 45%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 2.9% per year. Mediclinic International's return on equity is 5.1%, and it has net margins of 5%.
Key information
45.0%
Earnings growth rate
45.0%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 2.9% |
| Return on equity | 5.1% |
| Net Margin | 5.0% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Mediclinic International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 3,383 | 169 | 231 | 0 |
| 30 Jun 22 | 3,308 | 160 | 222 | 0 |
| 31 Mar 22 | 3,233 | 151 | 213 | 0 |
| 31 Dec 21 | 3,199 | 135 | 212 | 0 |
| 30 Sep 21 | 3,165 | 118 | 211 | 0 |
| 30 Jun 21 | 3,080 | 93 | 208 | 0 |
| 31 Mar 21 | 2,995 | 68 | 205 | 0 |
| 31 Dec 20 | 2,987 | -173 | 198 | 0 |
| 30 Sep 20 | 2,979 | -414 | 190 | 0 |
| 30 Jun 20 | 3,031 | -367 | 190 | 0 |
| 31 Mar 20 | 3,083 | -320 | 190 | 0 |
| 31 Dec 19 | 3,070 | -97 | 329 | 0 |
| 30 Sep 19 | 3,057 | 126 | 468 | 0 |
| 30 Jun 19 | 2,995 | -12 | 593 | 0 |
| 31 Mar 19 | 2,932 | -151 | 717 | 0 |
| 31 Dec 18 | 2,897 | -380 | 728 | 0 |
| 30 Sep 18 | 2,861 | -610 | 739 | 0 |
| 30 Jun 18 | 2,869 | -551 | 741 | 0 |
| 31 Mar 18 | 2,876 | -492 | 743 | 0 |
| 31 Dec 17 | 2,874 | -211 | 742 | 0 |
| 30 Sep 17 | 2,871 | 69 | 741 | 0 |
| 30 Jun 17 | 2,810 | 149 | 715 | 0 |
| 31 Mar 17 | 2,749 | 229 | 689 | 0 |
| 31 Dec 16 | 2,565 | 210 | 667 | 0 |
| 30 Sep 16 | 2,380 | 191 | 644 | 0 |
| 30 Jun 16 | 2,244 | 184 | 599 | 0 |
| 31 Mar 16 | 2,107 | 177 | 554 | 0 |
| 31 Dec 15 | 2,080 | 211 | 527 | 0 |
| 30 Sep 15 | 2,183 | 257 | 530 | 0 |
| 30 Jun 15 | 2,042 | 245 | 492 | 0 |
| 31 Mar 15 | 1,977 | 241 | 471 | 0 |
| 31 Dec 14 | 1,901 | 221 | 433 | 0 |
| 30 Sep 14 | 1,810 | 199 | 399 | 0 |
| 30 Jun 14 | 1,751 | 193 | 382 | 0 |
| 31 Mar 14 | 1,738 | 193 | 374 | 0 |
| 31 Dec 13 | 1,652 | 82 | 360 | 0 |
| 30 Sep 13 | 1,653 | -33 | 366 | 0 |
| 30 Jun 13 | 1,701 | -55 | 377 | 0 |
| 31 Mar 13 | 1,742 | -79 | 387 | 0 |
| 31 Dec 12 | 1,729 | 19 | 386 | 0 |
| 30 Sep 12 | 1,730 | 118 | 388 | 0 |
| 30 Jun 12 | 1,759 | 109 | 397 | 0 |
Quality Earnings: MDCL has high quality earnings.
Growing Profit Margin: MDCL's current net profit margins (5%) are higher than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDCL's earnings have grown significantly by 45% per year over the past 5 years.
Accelerating Growth: MDCL's earnings growth over the past year (43.2%) is below its 5-year average (45% per year).
Earnings vs Industry: MDCL earnings growth over the past year (43.2%) exceeded the Healthcare industry 3.8%.
Return on Equity
High ROE: MDCL's Return on Equity (5.1%) is considered low.